The Dengue Prevention Boards are modeled after the successful Viral Hepatitis Prevention Board (www.vhpb.org) which has been effectively promoting the cause of hepatitis vaccination, prevention and control in the Europe region for more than a decade. As noted in the VHPB Mission Statement:

 The objective of VHPB is to contribute to the control and prevention of viral hepatitis, by drawing the attention to this important public health problem, by issuing prevention guidelines, and by encouraging actions to improve control and prevention. VHPB focus audiences are, in the first instance, health care professionals, policymakers, and opinion leaders.

 The Pediatric Dengue Vaccine Initiative (PDVI) has helped to found two Boards to address the need for authoritative independent information about dengue. One Board focuses on the Americas and the other on the Asia-Pacific region. The Boards are composed of independent specialists in public health, clinical medicine and laboratory science, all of whom have expertise in aspects of dengue prevention and control. The Boards identify, recommend and promote best contemporary practice and needed research in dengue prevention and control in their respective regions with a special concern for the needs of the poor. They identify needs for capacity building and can participate in programs to create the needed capacities.
The Boards recognize that dengue prevention in the region will ultimately require sustained and high uptake of an effective and safe vaccine.
The Boards recognize that dengue prevention and control require a multidisciplinary approach including:

• Diagnostics
• Surveillance
• Burden of diseases
• Case management
• Vector control
• Health education
• Vaccines